NCT00532740View on ClinicalTrials.gov

Radiolabeled Glass Beads in Treating Patients With Metastatic Liver Cancer That Cannot Be Removed by Surgery

CompletedOBSERVATIONAL
Enrollment

2,000

Participants

Timeline

Start Date

December 31, 2004

Primary Completion Date

March 16, 2022

Study Completion Date

March 16, 2022

Conditions
Liver CancerMetastatic Cancer
Interventions
RADIATION

Yttrium Y 90 glass microspheres

Between 0.2 to 0.5 Curies (200-500-mCi), either single dose to the whole liver, or lobar treatment delivered as a sequence of treatments approximately 30 -90 days apart per treating physician's discretion.

Trial Locations (1)

60611-3013

Robert H. Lurie Comprehensive Cancer Center at Northwestern University, Chicago

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Northwestern University

OTHER

NCT00532740 - Radiolabeled Glass Beads in Treating Patients With Metastatic Liver Cancer That Cannot Be Removed by Surgery | Biotech Hunter | Biotech Hunter